publication venue for
- Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era. 2025
- Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy.. 110:651-664. 2025
- Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.. 110:1105-1114. 2024
- Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.. 109:3739-3744. 2024
- Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.. 109:2732-2737. 2024
- Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.. 108:3321-3332. 2023
- Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma.. 108:3477-3479. 2023
- FLT3. 108:2234-2239. 2023
- Prephase rituximab/prednisone therapy and aging-related, pro-inflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma. 107:1144-1152. 2022
- Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies.. 107:1172-1180. 2022
- Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?. 106:2544-2554. 2021
- Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.. 106:255-258. 2021
- Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide.. 102:932-940. 2017
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.. 102:391-400. 2016
- Aging and malignant hemopathies.. 100:571-4. 2015
- Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation 2024